281 related articles for article (PubMed ID: 30497810)
1. Testicular Cancer Biomarkers: A Role for Precision Medicine in Testicular Cancer.
Leão R; Ahmad AE; Hamilton RJ
Clin Genitourin Cancer; 2019 Feb; 17(1):e176-e183. PubMed ID: 30497810
[TBL] [Abstract][Full Text] [Related]
2. miRNAs orchestration of testicular germ cell tumors - Particular emphasis on diagnosis, progression and drug resistance.
Elesawy AE; Abulsoud AI; Moustafa HAM; Elballal MS; Sallam AM; Elazazy O; El-Dakroury WA; Abdel Mageed SS; Abdelmaksoud NM; Midan HM; Shahin RK; Elrebehy MA; Nassar YA; Elazab IM; Elballal AS; Elballal MS; Doghish AS
Pathol Res Pract; 2023 Aug; 248():154612. PubMed ID: 37327566
[TBL] [Abstract][Full Text] [Related]
3. miRNAs for testicular germ cell tumours: Contemporary indications for diagnosis, surveillance and follow-up.
Chavarriaga J; Hamilton RJ
Andrology; 2023 May; 11(4):628-633. PubMed ID: 36373757
[TBL] [Abstract][Full Text] [Related]
4. Serum tumour markers in germ cell tumours: From diagnosis to cure.
Pedrazzoli P; Rosti G; Soresini E; Ciani S; Secondino S
Crit Rev Oncol Hematol; 2021 Mar; 159():103224. PubMed ID: 33493632
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Bezan A; Gerger A; Pichler M
Anticancer Res; 2014 Jun; 34(6):2709-13. PubMed ID: 24922631
[TBL] [Abstract][Full Text] [Related]
6. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
[TBL] [Abstract][Full Text] [Related]
7. Testicular cancer.
Hellerstedt BA; Pienta KJ
Curr Opin Oncol; 2002 May; 14(3):260-4. PubMed ID: 11981269
[TBL] [Abstract][Full Text] [Related]
8. New prognostic markers and potential therapeutic targets in human testicular germ cell tumors.
Chieffi P
Curr Med Chem; 2011; 18(33):5033-40. PubMed ID: 22050751
[TBL] [Abstract][Full Text] [Related]
9. Testicular Germ Cell Tumors: Serological and Immunohistochemical Diagnosis.
Damjanov I
Acta Med Acad; 2021 Apr; 50(1):58-70. PubMed ID: 34075764
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in molecular and cell biology of testicular germ-cell tumors.
Chieffi P
Int Rev Cell Mol Biol; 2014; 312():79-100. PubMed ID: 25262239
[TBL] [Abstract][Full Text] [Related]
11. [EAU guidelines on testicular cancer: 2011 update. European Association of Urology].
Albers P; Albrecht W; Algaba F; Bokemeyer C; Cohn-Cedermark G; Fizazi K; Horwich A; Laguna MP;
Actas Urol Esp; 2012 Mar; 36(3):127-45. PubMed ID: 22188753
[TBL] [Abstract][Full Text] [Related]
12. Current Clinical Applications of Testicular Cancer Biomarkers.
Mir MC; Pavan N; Gonzalgo ML
Urol Clin North Am; 2016 Feb; 43(1):119-25. PubMed ID: 26614034
[TBL] [Abstract][Full Text] [Related]
13. Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice.
Chovanec M; Albany C; Mego M; Montironi R; Cimadamore A; Cheng L
Front Oncol; 2018; 8():571. PubMed ID: 30547014
[TBL] [Abstract][Full Text] [Related]
14. An Overview on Predictive Biomarkers of Testicular Germ Cell Tumors.
Chieffi P
J Cell Physiol; 2017 Feb; 232(2):276-280. PubMed ID: 27405110
[TBL] [Abstract][Full Text] [Related]
15. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
Canil CM; Tannock IF
Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.
Chovanec M; Cierna Z; Miskovska V; Machalekova K; Svetlovska D; Kalavska K; Rejlekova K; Spanik S; Kajo K; Babal P; Mardiak J; Mego M
Oncotarget; 2017 Mar; 8(13):21794-21805. PubMed ID: 28423520
[TBL] [Abstract][Full Text] [Related]
17. The search for biomarkers of metastatic seminoma.
Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
[TBL] [Abstract][Full Text] [Related]
18. Εmerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors.
Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Kawai T; Tanaka Y;
Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
[TBL] [Abstract][Full Text] [Related]
20. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
Syring I; Bartels J; Holdenrieder S; Kristiansen G; Müller SC; Ellinger J
J Urol; 2015 Jan; 193(1):331-7. PubMed ID: 25046619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
